Slansky Jr F
J Chem Ecol. 2013; 19(11):2635-50.
PMID: 24248717
DOI: 10.1007/BF00980697.
Lau C, Wang J
Psychopharmacology (Berl). 1996; 126(2):115-24.
PMID: 8856830
DOI: 10.1007/BF02246346.
CZOK G
Z Ernahrungswiss. 1980; 19(4):290-5.
PMID: 7467488
DOI: 10.1007/BF02023791.
Hartmann M, CZOK G
Z Ernahrungswiss. 1980; 19(3):215-27.
PMID: 7445577
DOI: 10.1007/BF02018787.
Newton R, Broughton L, Lind M, Morrison P, Rogers H, Bradbrook I
Eur J Clin Pharmacol. 1981; 21(1):45-52.
PMID: 7333346
DOI: 10.1007/BF00609587.
Pharmacokinetic aspects of caffeine in premature infants with apnoea.
Gorodischer R, Karplus M
Eur J Clin Pharmacol. 1982; 22(1):47-52.
PMID: 7094974
DOI: 10.1007/BF00606424.
Comparative pharmacokinetics of caffeine in young and elderly men.
Blanchard J, Sawers S
J Pharmacokinet Biopharm. 1983; 11(2):109-26.
PMID: 6886969
DOI: 10.1007/BF01061844.
The absolute bioavailability of caffeine in man.
Blanchard J, Sawers S
Eur J Clin Pharmacol. 1983; 24(1):93-8.
PMID: 6832208
DOI: 10.1007/BF00613933.
Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test.
Wietholtz H, Voegelin M, Arnaud M, BIRCHER J, Preisig R
Eur J Clin Pharmacol. 1981; 21(1):53-9.
PMID: 6800827
DOI: 10.1007/BF00609588.
Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives.
Abernethy D, Todd E
Eur J Clin Pharmacol. 1985; 28(4):425-8.
PMID: 4029248
DOI: 10.1007/BF00544361.
Caffeine disposition in obesity.
Abernethy D, Todd E, Schwartz J
Br J Clin Pharmacol. 1985; 20(1):61-6.
PMID: 4027137
PMC: 1400629.
DOI: 10.1111/j.1365-2125.1985.tb02799.x.
Factors influencing the caffeine test for cytochrome P 448-dependent liver function.
Joeres R, Klinker H, Huesler H, Epping J, Hofstetter G, Drost D
Arch Toxicol. 1987; 60(1-3):93-4.
PMID: 3619652
DOI: 10.1007/BF00296957.
Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.
Butler M, Iwasaki M, Guengerich F, Kadlubar F
Proc Natl Acad Sci U S A. 1989; 86(20):7696-700.
PMID: 2813353
PMC: 298137.
DOI: 10.1073/pnas.86.20.7696.
Clinical pharmacokinetics of non-opiate abused drugs.
Busto U, Bendayan R, Sellers E
Clin Pharmacokinet. 1989; 16(1):1-26.
PMID: 2565176
DOI: 10.2165/00003088-198916010-00001.
The caffeine breath test and caffeine urinary metabolite ratios in the Michigan cohort exposed to polybrominated biphenyls: a preliminary study.
Lambert G, Schoeller D, Humphrey H, Kotake A, LIETZ H, Campbell M
Environ Health Perspect. 1990; 89:175-81.
PMID: 1965165
PMC: 1567793.
DOI: 10.1289/ehp.9089175.
